BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19285749)

  • 1. Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer.
    Gu T; Ohashi R; Cui R; Tajima K; Yoshioka M; Iwakami S; Sasaki S; Shinohara A; Matsukawa T; Kobayashi J; Inaba Y; Takahashi K
    Lung Cancer; 2009 Nov; 66(2):176-83. PubMed ID: 19285749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
    Cho HJ; Kim JK; Kim KD; Yoon HK; Cho MY; Park YP; Jeon JH; Lee ES; Byun SS; Lim HM; Song EY; Lim JS; Yoon DY; Lee HG; Choe YK
    Cancer Lett; 2006 Jun; 237(1):56-66. PubMed ID: 16009487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
    Guo L; Zhou Y; Sun Y; Zhang F
    Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.
    Khodadadian M; Leroux ME; Auzenne E; Ghosh SC; Farquhar D; Evans R; Spohn W; Zou Y; Klostergaard J
    Lung Cancer; 2009 Oct; 66(1):48-57. PubMed ID: 19195736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells.
    Wang L; Chanvorachote P; Toledo D; Stehlik C; Mercer RR; Castranova V; Rojanasakul Y
    Mol Pharmacol; 2008 Jan; 73(1):119-27. PubMed ID: 17911532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
    Ikeguchi M; Nakamura S; Kaibara N
    Oncol Rep; 2002; 9(5):1121-6. PubMed ID: 12168083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
    Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA
    Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy resistance of mouse WAP-SVT/t breast cancer cells is mediated by osteopontin, inhibiting apoptosis downstream of caspase-3.
    Graessmann M; Berg B; Fuchs B; Klein A; Graessmann A
    Oncogene; 2007 May; 26(20):2840-50. PubMed ID: 17160024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
    Cui R; Takahashi F; Ohashi R; Yoshioka M; Gu T; Tajima K; Unnoura T; Iwakami S; Hirama M; Ishiwata T; Iwase A; Takahashi K
    Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells.
    Wang J; Liu X; Jiang W
    Chin Med J (Engl); 2000 Oct; 113(10):957-60. PubMed ID: 11775848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation.
    Chanvorachote P; Pongrakhananon V; Wannachaiyasit S; Luanpitpong S; Rojanasakul Y; Nimmannit U
    Cancer Invest; 2009 Jul; 27(6):624-35. PubMed ID: 19283527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement.
    Clarke DM; Baust JM; Van Buskirk RG; Baust JG
    Cryobiology; 2004 Aug; 49(1):45-61. PubMed ID: 15265716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
    Moritaka T; Kiura K; Ueoka H; Tabata M; Segawa Y; Shibayama T; Takigawa N; Ohnoshi T; Harada M
    Anticancer Res; 1998; 18(2A):927-33. PubMed ID: 9615743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.